At a glance
ClinicalIndex Comparison RecordN/AActive· 180 target
Drug / intervention
Transvaginal mesh for anterior pelvic organ prolapse repairdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multicenter, 60 Months, Single Arm Cohort Study to Evaluate the Efficacy and Safety of the Ultra-Light-Weight Mesh CAlistar S in Transvaginal Pelvic Organ Prolapse Repair
In Brief
A clinical study evaluating Transvaginal mesh for anterior pelvic organ prolapse repair for Pelvic Organ Prolapse. Active but no longer recruiting, targeting 180 participants across 6 sites.
Detailed Summary
Prospective long-term evaluation of the performance and safety of Calistar S for transvaginal pelvic organ prolapse repair in women with anterior POP with or without apical vaginal involvement
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPelvic Organ Prolapse
CountriesGermany
Collaborators--
Timeline
N/AActive
201920202021202220232024202520262027202820292030
First PostedJan 2019
Enrollment StartMar 2021
TodayJul 2026
Primary CompletionOct 2026
Study CompletionOct 2029
First PostedJan 29, 2019
Enrollment StartMar 10, 2021
Primary CompletionOct 1, 2026
Study CompletionOct 1, 2029
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 7.4 years agoPrimary completion in 3 months
Interventions
Transvaginal mesh for anterior pelvic organ prolapse repairdevice
synthetic mesh for anterior pelvic organ prolapse with or without apical vaginal wall involvement via the vaginal route in a highly selected patient population